MedPath

Effects of Exercise Training in Patients With Permanent Atrial Fibrillation

Phase 1
Completed
Conditions
Atrial Fibrillation
Interventions
Other: Exercise training
Registration Number
NCT01721863
Lead Sponsor
National Taiwan University Hospital
Brief Summary

Atrial fibrillation (AF) is a common arrhythmia. The proposed patholophysiological mechanisms of AF include abnormal electrical conduction in atrium and sympathovagal imbalance with increased vagal tone. Patients with AF have poor exercise capacity that may contribute to decreased atrial effective refractory period, and decreased cardiac output and heart rate reserve, and may result in poor quality of life. Poor endothelial function had been noted in patients with AF, associated with increased risks of cerebrovascular and cardiovascular disease. Exercise training has been noted to improve exercise capacity and quality of life in patients with AF only in some studies. Endothelial function can be improved by exercise training in patients with cardiovascular disease, but no report in patients with AF. Evidence of exercise training is still needed in patients with AF. The purpose of this study is to investigate the effect of exercise training on

1. endothelial function

2. heart rate variability

3. exercise capacity

4. quality of life.

Detailed Description

A randomized controlled study was implemented to examine :(1) the effect of interval aerobic exercise training combined with resistance training on endothelial function, heart rate variability (HRV), exercise capacity, and quality of life (QoL); (2) the influential factors related to exercise capacity, and the relationship between exercise capacity and quality of life in patients with permanent atrial fibrillation (AF).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
58
Inclusion Criteria
  • Permanent atrial fibrillation≥ 1 year aged 40-76 years
  • Recurrence AF after ablation
  • Under antiarrhythmia medication control
Read More
Exclusion Criteria
  • CAD or myocardial infrarction history
  • NYHA≥ III-IV, or LVEF≤45%
  • Mitral or aortic valve regurgitation ≥ Gr. II
  • Mitral valve or aortic valve stenosis
  • Pacemaker
  • Cardioversion by ablation
  • Pulmonary artery hypertension
  • Any surgery in previous 3 months
  • Any neurological disorders
  • Cancer
  • Severe musculoskeletal disorder
  • Hyperthyroidism
  • Premenopausal women
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Exercise trainingExercise trainingExercise group will undergo progressively aerobic exercise training with 40-85% maximal oxygen consumption for 40 minutes, 3 sessions per week for 12 weeks.
Primary Outcome Measures
NameTimeMethod
Change of exercise capacity (after intervention)At baseline and 12 weeks after intervention

To measure maximal oxygen consumption, maximal oxygen pulse, maximal heart rate and blood pressure, cumulated and peak workload by cycle ergometer with Vmax 229 system

Secondary Outcome Measures
NameTimeMethod
Change of heart rate variability (after intervention)At baseline and 12 weeks after intervention

To record ECG by lead V1 with KENZ 170 on supine position for 1 hour

Change values of head up tilt test (after intervention)At baseline and 12 weeks after intervention

Subjects were tilted up 60 degree on tilting table for 15 minutes to record the change of blood pressure and heart rate, and heart rate variability.

Change of endothelial function (after intervention)At baseline and 12 weeks after intervention

To measure dependent-endothelial moulation by flow-mediated dilatation with Sonosite 180 portable ultrasound.

Change of quality of life (after intervention)At baseline and 12 weeks after intervention

To measure quality of life by Short-form 36 and symptom checklist

Trial Locations

Locations (1)

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath